 | |
| Formation | January 9, 1986[1] |
|---|---|
| Type | Public policy think tank |
| 52-1449368 | |
| Headquarters | 1629 K Street N.W., Suite 600, Washington, D.C., U.S. |
| Location |
|
Executive Director | Mark Krikorian[2] |
| Website | www |
The Center for Immigration Studies (CIS) is an American anti-immigration think tank. It favors far lower immigration numbers and produces analyses to further those views. The CIS was founded by historian Otis L. Graham and eugenicist and white nationalist John Tanton in 1985 as a spin-off of the Federation for American Immigration Reform (FAIR). It is one of a number of anti-immigration organizations founded by Tanton, along with FAIR and NumbersUSA.
Reports published by CIS have been disputed by scholars on immigration, fact-checkers and news outlets, and immigration-research organizations. The organization had significant influence within the Trump administration,[3] which cited the group's work to defend its immigration policies.[4] The Southern Poverty Law Center designated CIS as a hate group with ties to the American nativist movement.[5] The CIS sued the SPLC over the designation, but the lawsuit was dismissed.[6][7][8]
- ^ "Center for Immigration Studies". OpenCorporates. Retrieved April 1, 2017.
- ^ "Center for Immigration Studies Staff List – Center for Immigration Studies". cis.org.
- ^ Alemany, Jacqueline (May 22, 2019). "Power Up: Trump's new immigration coordinator has a lot to coordinate". The Washington Post.
- ^ Lopez, Luciana. "Two hawkish anti-immigration groups say consulted by Trump". Reuters. Retrieved August 16, 2018.
- ^ Cite error: The named reference
SPLCwas invoked but never defined (see the help page). - ^ Bixby, Scott (January 16, 2019). "Anti-Immigration Group Uses Mafia Law to Attack SPLC". Retrieved February 20, 2019.
- ^ U.S. District Court for the District of Columbia (September 13, 2019) "Memorandum & Opinion"
- ^ Kunzelman, Michael (September 16, 2019). "Judge tosses lawsuit over law center's hate group labels". Associated Press. Retrieved September 16, 2019.